Pharmacie Smits Basse Wavre
0839.193.421 · rovalta.com · 26/09/2026
Pharmacie Smits Basse Wavre
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPharmacie Smits Basse Wavre is a Private company with limited liability incorporated in 2011. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Wavre. It employs on average 3,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0839.193.421
- Incorporation
- 09/09/2011
- Legal form
- Private company with limited liability
- Registered office
- Chaussée de Louvain 266
1300 Wavre · WallonieSee on map - Contributed capital
- 20 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 3,4 ETP
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 470,2 k € | -17.4% | 569,1 k € | +23.8% | 459,7 k € | -18.6% | 564,9 k € | -1.4% | 572,7 k € |
| EBITDA | 216 k € | +1.9% | 211,9 k € | +66.4% | 127,4 k € | -47.0% | 240,2 k € | -12.3% | 274 k € |
| Operating result | 125,4 k € | -15.6% | 148,6 k € | +137% | 62,7 k € | -63.0% | 169,6 k € | -6.6% | 181,5 k € |
| Net result | 61,6 k € | -20.8% | 77,8 k € | +279% | 20,5 k € | -80.6% | 106,1 k € | -4.3% | 110,8 k € |
| Balance sheet | |||||||||
| Equity | 414,1 k € | +17.5% | 352,5 k € | +28.3% | 274,7 k € | +2.9% | 266,9 k € | +10.8% | 240,8 k € |
| Total assets | 1,2 M € | -2.0% | 1,3 M € | +9.4% | 1,2 M € | -13.6% | 1,3 M € | -0.7% | 1,3 M € |
| Cash | 193,6 k € | +40.6% | 137,7 k € | +40.5% | 98 k € | -5.7% | 103,9 k € | -30.1% | 148,8 k € |
| Debts | 823,5 k € | -9.6% | 910,4 k € | +3.6% | 879 k € | -17.7% | 1,1 M € | -2.8% | 1,1 M € |
| Other | |||||||||
| Workforce | 3,4 ETP | -19.0% | 4,2 ETP | -2.3% | 4,3 ETP | -15.7% | 5,1 ETP | +13.3% | 4,5 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/2025Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 08/07/2026 | 11/07/2025 | 04/07/2024 | 29/06/2023 | 15/07/2022 | 30/06/2021 |
| General meeting | 04/06/2026 | 05/06/2025 | 06/06/2024 | 01/06/2023 | 02/06/2022 | 03/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 04/06/2026 | 08/07/2026 | French | |
| Abridged model | 31/12/2024 | 05/06/2025 | 11/07/2025 | French | |
| Abridged model | 31/12/2023 | 06/06/2024 | 04/07/2024 | French | |
| Abridged model | 31/12/2022 | 01/06/2023 | 29/06/2023 | French | |
| Abridged model | 31/12/2021 | 02/06/2022 | 15/07/2022 | French | |
| Abridged model | 31/12/2020 | 03/06/2021 | 30/06/2021 | French | |
| Abridged model | 31/12/2019 | 04/06/2020 | 17/07/2020 | French | |
| Abridged model | 31/12/2018 | 06/06/2019 | 17/06/2019 | French | |
| Abridged model | 31/12/2017 | 07/06/2018 | 16/07/2018 | French | |
| Abridged model | 31/12/2016 | 01/06/2017 | 19/07/2017 | French | |
| Abridged model | 31/12/2015 | 02/06/2016 | 01/08/2016 | French | |
| Abridged model | 31/12/2014 | 04/06/2015 | 30/07/2015 | French | |
| Abridged model | 31/12/2013 | 05/06/2014 | 17/07/2014 | French | |
| Abridged model | 31/12/2012 | 06/06/2013 | 24/07/2013 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates25/02/2019DEMISSIONS, NOMINATIONS
- Restructuring04/02/2019DENOMINATION - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring05/11/2018RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates06/02/2012DEMISSIONS, NOMINATIONS
- Other13/09/2011RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202561,6 k €↓
- 2024Annual accounts 202477,8 k €↑
- 2023Annual accounts 202320,5 k €↓
- 2022Annual accounts 2022106,1 k €↓
- 2021Annual accounts 2021110,8 k €↑
- 2021Name changeSMITS BASSE WAVRE
- 2020Annual accounts 202094,2 k €↑
- 2019Annual accounts 201991,6 k €↑
- 2018Annual accounts 201864,5 k €↓
- 2018Name changePharmacie Smits Basse Wavre
- 2017Annual accounts 201788 k €↓
- 2016Annual accounts 201695,3 k €↑
- 2015Annual accounts 2015-23,9 k €↓
- 2014Annual accounts 2014-2,2 k €↑
- 2013Annual accounts 2013-50,3 k €↓
- 2012Annual accounts 2012-8,2 k €
- 2012Name changePharma Project IV
- 09/09/2011IncorporationPrivate company with limited liability